ProfileGDS4718 / 1559582_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 37% 36% 43% 42% 42% 42% 46% 36% 36% 41% 40% 43% 38% 46% 42% 48% 42% 49% 47% 48% 29% 42% 36% 42% 42% 45% 42% 47% 41% 47% 42% 48% 40% 44% 46% 47% 47% 40% 43% 42% 43% 44% 48% 47% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.8698337
GSM549102patient 115, normal, homogenized [OPG study]4.8340436
GSM549104patient 119, normal, homogenized [OPG study]5.1300343
GSM549108patient 138, normal, homogenized [OPG study]5.1539842
GSM549119patient 077, normal, homogenized [OPG study]5.0824342
GSM549133patient 032, cancer, homogenized [OPG study]5.0239142
GSM549139patient 042, cancer, homogenized [OPG study]5.2687446
GSM549099patient 107, normal, homogenized [OPG study]4.8172236
GSM549109patient 139, normal, homogenized [OPG study]4.8261336
GSM549110patient 046, normal, homogenized [OPG study]5.0327341
GSM549114patient 063, normal, homogenized [OPG study]4.9486940
GSM549122patient 082, normal, homogenized [OPG study]5.1210143
GSM549134patient 033, cancer, homogenized [OPG study]4.9049138
GSM549136patient 036, cancer, homogenized [OPG study]5.2313146
GSM549140patient 044, cancer, homogenized [OPG study]5.0334142
GSM549111patient 047, normal, homogenized [OPG study]5.3916748
GSM549113patient 057, normal, homogenized [OPG study]5.0093342
GSM549132patient 031, cancer, homogenized [OPG study]5.4666849
GSM549137patient 038, cancer, homogenized [OPG study]5.3086947
GSM549142patient 047, cancer, homogenized [OPG study]5.5074348
GSM549100patient 110, normal, homogenized [OPG study]4.5125429
GSM549107patient 135, normal, homogenized [OPG study]5.0500142
GSM549115patient 068, normal, homogenized [OPG study]4.7543936
GSM549116patient 072, normal, homogenized [OPG study]5.0546942
GSM549120patient 078, normal, homogenized [OPG study]5.1012542
GSM549131patient 030, cancer, homogenized [OPG study]5.1711245
GSM549118patient 074, normal, homogenized [OPG study]5.0780642
GSM549129patient 027, cancer, homogenized [OPG study]5.3961547
GSM549123patient 088, normal, homogenized [OPG study]5.0202841
GSM549124patient 006, cancer, homogenized [OPG study]5.378547
GSM549126patient 015, cancer, homogenized [OPG study]5.081342
GSM549128patient 025, cancer, homogenized [OPG study]5.410448
GSM549103patient 117, normal, homogenized [OPG study]5.0419940
GSM549117patient 073, normal, homogenized [OPG study]5.162644
GSM549138patient 041, cancer, homogenized [OPG study]5.3002546
GSM549141patient 045, cancer, homogenized [OPG study]5.3069747
GSM549130patient 028, cancer, homogenized [OPG study]5.3517647
GSM549101patient 111, normal, homogenized [OPG study]5.0104840
GSM549105patient 128, normal, homogenized [OPG study]5.1778743
GSM549106patient 134, normal, homogenized [OPG study]5.0396142
GSM549112patient 048, normal, homogenized [OPG study]5.1459443
GSM549125patient 011, cancer, homogenized [OPG study]5.2265244
GSM549127patient 024, cancer, homogenized [OPG study]5.397648
GSM549135patient 035, cancer, homogenized [OPG study]5.3131247